Connect with us

Headlines

Capping stent prices to affect patients, slab pricing right way: Ramadoss


Chennai, April 28 The central government's move to cap the stent prices may backfire and affect Indian patients and also the medical tourism potential, former Union Health Minister Anbumani Ramadoss said on Friday.

He also said making doctors prescribe drugs by their generic names was a good move but the issue of drug quality check had to be strengthened.

Ramadoss, a qualified medical doctor, told IANS that "capping the prices of stents may make manufacturers exit the Indian market which in turn would affect the patients".

According to him, Indian patients would be affected to a large extent and so would be in-bound medical tourism (foreign patients coming to India for surgeries/treatment) into India.

"The government should have stipulated prices on slab basis. There should be two or three slabs on pricing of stents," Ramadoss said.

The National Pharmaceutical Pricing Authority capped the prices of drug eluting stents (DES) and bioresorbable stents at Rs 29,600, and that of bare metal stents at Rs 7,260 in February-excluding local taxes.

The medical devices industry had suggested to the government that the stent's average price to the hospital should be the basis for arriving at the price band.

Ramadoss, a Lok Sabha member of the PMK from Tamil Nadu's Dharmapuri, agreed with the industry's fear that companies may reduce their research and development (R&D) spend and exit the Indian market if the revised prices do not cover even the cost.

Terming the Centre's move to make doctors prescribe drugs by their generic name and not by their brand name as "good", Ramadoss said quality checks of drugs made in India have to beefed up.

"The drug quality is a state subject in India. In India checking drug quality is an issue," he said.

According to him, the chemist will now try to push products of those manufacturers who give him higher margins.

In a recent report, investment banking firm Jefferies had said: "In our view, without steps for improving quality standards for drugs available in the market, the move will not have much material impact and will shift power from doctors to pharmacists."

According to Jefferies, transition to generics is a long term aim where the first step needs to be quality.








1 hour ago
US Navy's supply ship Wally Schirra arrives at Kattupalli port for repairs
1 hour ago
'Biased organisation with blatantly political agenda': India condemns USCIRF again
2 hours ago
What Happens When Your Neighbors Turn Detectives? Vijay Sethupathi Unveils the Trailer of ‘Octopus’, Premiering November 27 on Zee 5 Global
2 hours ago
Zee TV Brings a Heartwarming Tale of Family, Love and Relationships with ‘Shubh Shagun Shehnaiya’, Premiering November 30
3 hours ago
Canada: Punjab-origin man, his girlfriend killed in shooting in Surrey, investigation underway
4 hours ago
Paris Hilton celebrates daughter London’s 3rd b’day, calls motherhood ‘magical gift’
4 hours ago
Esha Deol’s ex-husband Bharat Takhtani reunites with her at her film screening, Hema Malini seems awkward
4 hours ago
Lalit Modi shares sweet birthday wish for former girlfriend Sushmita Sen, calls her ‘dear friend’
4 hours ago
OM Review: Dhanush unleashes a power-packed mass avatar; Mammootty impresses, Sai Pallavi steals the show and Sreeleela shines
4 hours ago
Ankita Lokhande recalls quitting industry just before ‘Pavitra Rishta’ call, says she was mobbed with Sushant Singh Rajput
4 hours ago
Sanjay Kapoor on playing a cop in ‘Unexpected Safed Sach:’ ‘Women’s safety is our collective responsibility’
4 hours ago
Joju George's 'Paripadi' makers reveal Leo Tharakan's character in film
4 hours ago
Samantha Ruth Prabhu welcomes baby boy, shares first glimpse and reveals his name